Vyome Holdings Files 8-K/A Amendment
Ticker: HIND · Form: 8-K/A · Filed: Sep 12, 2025 · CIK: 1427570
| Field | Detail |
|---|---|
| Company | Vyome Holdings, Inc (HIND) |
| Form Type | 8-K/A |
| Filed Date | Sep 12, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, financial-statements, exhibits
TL;DR
Vyome Holdings filed an 8-K/A amendment on Sept 12, updating a Sept 2 report. Details on financials/exhibits.
AI Summary
Vyome Holdings, Inc. filed an amendment (8-K/A) on September 12, 2025, to a previous report concerning events on September 2, 2025. The filing pertains to financial statements and exhibits, with no specific financial figures or material events detailed in the provided text.
Why It Matters
This filing indicates an update or correction to a previous report, which could contain important information about the company's financial status or operational events.
Risk Assessment
Risk Level: low — The filing is an amendment to a previous report and does not disclose new material negative information.
Key Players & Entities
- Vyome Holdings, Inc. (company) — Registrant
- ReShape Lifesciences Inc. (company) — Former Company Name
- OBALON THERAPEUTICS INC (company) — Former Company Name
- September 12, 2025 (date) — Filing Date
- September 2, 2025 (date) — Earliest Event Date
FAQ
What is the purpose of this 8-K/A filing?
This 8-K/A filing is an amendment to a previous report, specifically concerning financial statements and exhibits, filed on September 12, 2025, relating to an event on September 2, 2025.
What was the earliest event date reported?
The earliest event date reported in this filing is September 2, 2025.
What is the company's principal executive office address?
The company's principal executive offices are located at Harvard Square, One Mifflin Place, Suite 400, Cambridge, MA 02138.
What is Vyome Holdings, Inc.'s IRS Employer Identification Number?
Vyome Holdings, Inc.'s IRS Employer Identification Number is 26-1828101.
Has Vyome Holdings, Inc. operated under any former names?
Yes, Vyome Holdings, Inc. formerly operated as ReShape Lifesciences Inc. and OBALON THERAPEUTICS INC.
Filing Stats: 497 words · 2 min read · ~2 pages · Grade level 11.5 · Accepted 2025-09-12 16:10:26
Key Financial Figures
- $0.001 — ich registered Common stock, par value $0.001 per share HIND The Nasdaq Capital M
Filing Documents
- ea0257032-8ka1_vyome.htm (8-K/A) — 27KB
- ea025703201ex99-1_vyome.htm (EX-99.1) — 184KB
- 0001213900-25-087217.txt ( ) — 401KB
- hind-20250902.xsd (EX-101.SCH) — 3KB
- hind-20250902_lab.xml (EX-101.LAB) — 33KB
- hind-20250902_pre.xml (EX-101.PRE) — 22KB
- ea0257032-8ka1_vyome_htm.xml (XML) — 4KB
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Unaudited Pro Forma Condensed Combined Financial Statements 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. VYOME HOLDINGS, INC. September 12, 2025 By: /s/ Venkat Nelabhotla Name: Venkat Nelabhotla Title: President & Chief Executive Officer 3